Chapter

The Role of Neuroimaging Biomarkers in Personalized Medicine for Neurodegenerative and Psychiatric Disorders

Ellen M. Migo, Steve C.R. Williams, William R. Crum, Matthew J. Kempton and Ulrich Ettinger

in Integrative Neuroscience and Personalized Medicine

Published in print December 2010 | ISBN: 9780195393804
Published online January 2011 | e-ISBN: 9780199863495 | DOI: http://dx.doi.org/10.1093/acprof:oso/9780195393804.003.0008
The Role of Neuroimaging Biomarkers in Personalized Medicine for Neurodegenerative and Psychiatric Disorders

Show Summary Details

Preview

There is a clear need for biomarkers in neuro-degenerative and psychiatric disorders for both early and differential diagnosis, personalized prediction of treatment response, and in drug discovery. Non-invasive neuroimaging is a key area for biomarker development because it connects behavioural outcomes with structural, functional, and molecular mechanisms. This chapter discusses neuroimaging biomarkers in relation to dementia, schizophrenia, and mood disorders (bipolar and major depressive disorders). The current candidate biomarkers for each disorder are reviewed, across the full range of imaging modalities, followed by an evaluation of their future prospects. The chapter concludes that there has been substantial progress towards personalized neuroimaging-based biomarkers but much remains to be done. Such biomarkers must be validated for specific disorders and may include neuroimaging and non-neuroimaging components.

Keywords: neuroimaging; biomarkers; dementia; schizophrenia; mood disorders; bipolar disorder; major depressive disorder

Chapter.  13306 words. 

Subjects: Neuroscience

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.